Ameriprise’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.71M Buy
189,620
+51,123
+37% +$730K ﹤0.01% 2767
2025
Q1
$1.45M Buy
138,497
+41,124
+42% +$432K ﹤0.01% 3032
2024
Q4
$1.18M Buy
97,373
+54,581
+128% +$661K ﹤0.01% 3150
2024
Q3
$629K Sell
42,792
-725,494
-94% -$10.7M ﹤0.01% 3395
2024
Q2
$11.1M Sell
768,286
-155,080
-17% -$2.24M ﹤0.01% 1659
2024
Q1
$15M Buy
923,366
+13,009
+1% +$212K ﹤0.01% 1485
2023
Q4
$13.6M Sell
910,357
-14,497
-2% -$216K ﹤0.01% 1528
2023
Q3
$10.4M Buy
924,854
+47,325
+5% +$532K ﹤0.01% 1679
2023
Q2
$8.83M Sell
877,529
-166,081
-16% -$1.67M ﹤0.01% 1880
2023
Q1
$9.81M Sell
1,043,610
-1,321
-0.1% -$12.4K ﹤0.01% 1790
2022
Q4
$12.8M Buy
1,044,931
+84,178
+9% +$1.03M ﹤0.01% 1542
2022
Q3
$11.9M Buy
960,753
+335,408
+54% +$4.16M ﹤0.01% 1528
2022
Q2
$12.3M Buy
625,345
+47,374
+8% +$930K ﹤0.01% 1567
2022
Q1
$15.1M Sell
577,971
-189,307
-25% -$4.93M ﹤0.01% 1572
2021
Q4
$21.7M Sell
767,278
-2,058,422
-73% -$58.3M 0.01% 1335
2021
Q3
$90.1M Sell
2,825,700
-433,553
-13% -$13.8M 0.03% 550
2021
Q2
$116M Buy
3,259,253
+296,323
+10% +$10.5M 0.04% 480
2021
Q1
$86.3M Buy
2,962,930
+157,766
+6% +$4.59M 0.03% 564
2020
Q4
$85.9M Buy
2,805,164
+889,777
+46% +$27.3M 0.03% 524
2020
Q3
$53.4M Buy
1,915,387
+1,148,235
+150% +$32M 0.02% 610
2020
Q2
$16.5M Sell
767,152
-53,238
-6% -$1.14M 0.01% 1181
2020
Q1
$18.4M Buy
820,390
+740,381
+925% +$16.6M 0.01% 986
2019
Q4
$2.36M Sell
80,009
-1,273,954
-94% -$37.5M ﹤0.01% 2648
2019
Q3
$36M Sell
1,353,963
-503,830
-27% -$13.4M 0.02% 811
2019
Q2
$62.8M Buy
1,857,793
+70,192
+4% +$2.37M 0.03% 570
2019
Q1
$57.3M Buy
1,787,601
+218,801
+14% +$7.02M 0.03% 594
2018
Q4
$49.5M Sell
1,568,800
-66,500
-4% -$2.1M 0.02% 628
2018
Q3
$57M Buy
+1,635,300
New +$57M 0.02% 690